Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ANGIODYNAMICS INC | ango-053116x10k.htm |
| EX-32.2 - EXHIBIT 32.2 - ANGIODYNAMICS INC | ex3225311610-k.htm |
| EX-32.1 - EXHIBIT 32.1 - ANGIODYNAMICS INC | ex3215311610-k.htm |
| EX-31.2 - EXHIBIT 31.2 - ANGIODYNAMICS INC | ex3125311610-k.htm |
| EX-31.1 - EXHIBIT 31.1 - ANGIODYNAMICS INC | ex3115311610-k.htm |
| EX-21 - EXHIBIT 21 - ANGIODYNAMICS INC | ex2153116.htm |
| EX-10.4.3 - EXHIBIT 10.4.3 - ANGIODYNAMICS INC | ex104353116.htm |
| EX-10.1.5 - EXHIBIT 10.1.5 - ANGIODYNAMICS INC | ex101553116.htm |
| EX-3.1.2 - EXHIBIT 3.1.2 - ANGIODYNAMICS INC | ex31253116.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (No. 333-190642) and on Form S-8 (No 333-120057, No. 333-138456, No. 333-140627, No. 333-161355, No. 333-162844, No. 333-170619, No. 333-190640 and No. 333-203441) of AngioDynamics, Inc. of our report dated August 1, 2016 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
Boston, Massachusetts
August 1, 2016